Codex DNA Inc reports results for the quarter ended in September - Earnings Summary

Telesis Bio

08/11/2022 23:49

* Codex DNA Inc  DNAY.OQ  reported a quarterly adjusted loss
of 42
cents​​ per share for the quarter ended in September. The mean
expectation of three analysts for the quarter was for a loss
of 48 cents per share.
    * Revenue rose 139.6% to $6.68 million from a year ago;
analysts
expected $5.30 million. 
    * Codex DNA Inc's reported EPS for the quarter was a loss
of 42
cents​.
    * The mean earnings estimate of analysts had risen by
about 5.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Codex DNA Inc shares had fallen by 3.6% this quarter and
lost 85.2% so far this year.
    * The company reported a quarterly loss of $12.31 million.
    * Wall Street's median 12-month price target for Codex DNA
Inc is
$8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 11:49 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.48          -0.42          Beat
 Jun. 30 2022      -0.51          -0.50          Beat
 Mar. 31 2022      -0.42          -0.45          Missed
 Dec. 31 2021      -0.37          -0.43          Missed